Skip to main content

PP242, mTOR inhibitor, decreases phenylephrine-induced vascular contractility in hypertensive and normotensive arteries

Publication ,  Conference
Quinones, PM; Patel, V; Lewis, S; McKenzie, J; Warner, A; McCarthy, C; Wenceslau, C; Komic, A; Webb, RC
Published in: FASEB JOURNAL
2019

Duke Scholars

Published In

FASEB JOURNAL

EISSN

1530-6860

ISSN

0892-6638

Publication Date

2019

Volume

33

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 3208 Medical physiology
  • 3101 Biochemistry and cell biology
  • 1116 Medical Physiology
  • 0606 Physiology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Quinones, P. M., Patel, V., Lewis, S., McKenzie, J., Warner, A., McCarthy, C., … Webb, R. C. (2019). PP242, mTOR inhibitor, decreases phenylephrine-induced vascular contractility in hypertensive and normotensive arteries. In FASEB JOURNAL (Vol. 33).
Quinones, Patricia Martinez, Viral Patel, Steven Lewis, Jaine McKenzie, Alex Warner, Cameron McCarthy, Camilla Wenceslau, Amel Komic, and R Clinton Webb. “PP242, mTOR inhibitor, decreases phenylephrine-induced vascular contractility in hypertensive and normotensive arteries.” In FASEB JOURNAL, Vol. 33, 2019.
Quinones PM, Patel V, Lewis S, McKenzie J, Warner A, McCarthy C, et al. PP242, mTOR inhibitor, decreases phenylephrine-induced vascular contractility in hypertensive and normotensive arteries. In: FASEB JOURNAL. 2019.
Quinones PM, Patel V, Lewis S, McKenzie J, Warner A, McCarthy C, Wenceslau C, Komic A, Webb RC. PP242, mTOR inhibitor, decreases phenylephrine-induced vascular contractility in hypertensive and normotensive arteries. FASEB JOURNAL. 2019.

Published In

FASEB JOURNAL

EISSN

1530-6860

ISSN

0892-6638

Publication Date

2019

Volume

33

Related Subject Headings

  • Biochemistry & Molecular Biology
  • 3208 Medical physiology
  • 3101 Biochemistry and cell biology
  • 1116 Medical Physiology
  • 0606 Physiology
  • 0601 Biochemistry and Cell Biology